Semiconductor production relies on over 150 chemicals and more than 30 gases and minerals, with their quality and reliability playing a crucial role in the success of the manufacturing process.
Under the terms of the deal, Hansoh Pharma would also receive royalties on sales, and may co-promote or solely commercialize the drug in China subject to certain conditions, the companies said in the statement.